Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays
In the pathogenesis of keratoconjunctivitis sicca, immune processes are thought to play an important role. However, the exact details of the pathomechanisms are still unknown. In this study, the expression patterns of proinflammatory cytokines in the tears of patients with different subtypes of dry...
Gespeichert in:
| Veröffentlicht in: | Investigative ophthalmology & visual science Jg. 52; H. 10; S. 7725 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
29.09.2011
|
| Schlagworte: | |
| ISSN: | 1552-5783, 1552-5783 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | In the pathogenesis of keratoconjunctivitis sicca, immune processes are thought to play an important role. However, the exact details of the pathomechanisms are still unknown. In this study, the expression patterns of proinflammatory cytokines in the tears of patients with different subtypes of dry eye were analyzed.
One hundred forty-three subjects subdivided into healthy controls (CTRL, n = 38), patients with aqueous-deficient dry eye (DRYaq, n = 35), patients with changes of the lipid layer (DRYlip, n = 36), and patients with a combination of both (DRYaplip, n = 34) were examined. Expression patterns of proteins (e.g., IL-1β, IL-6, ITNF-α, and IFN-γ) were examined using an advanced antibody microarray approach.
Several highly significant differences in the cytokine levels of dry eye patients compared with healthy controls were detected. Patients with DRYaq or those with DRYaplip showed elevated levels for most of the tested proteins. For example, IL-1β was found to be elevated 2.4-fold in DRYaq patients and 2.75-fold in DRYaqlip patients (both P < 8.00E-6). The detected amounts of protein in DRYlip patients and in healthy controls showed only minimal differences (fold increase/decrease for all proteins >1.2; P > 5.00E-1).
The similarity between the profiles of healthy controls and DRYlip patients justifies the assumption that the pathomechanism of this dry eye subtype is based on mechanisms other than inflammation, whereas it seems to be the case for DRYaq patients. |
|---|---|
| AbstractList | In the pathogenesis of keratoconjunctivitis sicca, immune processes are thought to play an important role. However, the exact details of the pathomechanisms are still unknown. In this study, the expression patterns of proinflammatory cytokines in the tears of patients with different subtypes of dry eye were analyzed.PURPOSEIn the pathogenesis of keratoconjunctivitis sicca, immune processes are thought to play an important role. However, the exact details of the pathomechanisms are still unknown. In this study, the expression patterns of proinflammatory cytokines in the tears of patients with different subtypes of dry eye were analyzed.One hundred forty-three subjects subdivided into healthy controls (CTRL, n = 38), patients with aqueous-deficient dry eye (DRYaq, n = 35), patients with changes of the lipid layer (DRYlip, n = 36), and patients with a combination of both (DRYaplip, n = 34) were examined. Expression patterns of proteins (e.g., IL-1β, IL-6, ITNF-α, and IFN-γ) were examined using an advanced antibody microarray approach.METHODSOne hundred forty-three subjects subdivided into healthy controls (CTRL, n = 38), patients with aqueous-deficient dry eye (DRYaq, n = 35), patients with changes of the lipid layer (DRYlip, n = 36), and patients with a combination of both (DRYaplip, n = 34) were examined. Expression patterns of proteins (e.g., IL-1β, IL-6, ITNF-α, and IFN-γ) were examined using an advanced antibody microarray approach.Several highly significant differences in the cytokine levels of dry eye patients compared with healthy controls were detected. Patients with DRYaq or those with DRYaplip showed elevated levels for most of the tested proteins. For example, IL-1β was found to be elevated 2.4-fold in DRYaq patients and 2.75-fold in DRYaqlip patients (both P < 8.00E-6). The detected amounts of protein in DRYlip patients and in healthy controls showed only minimal differences (fold increase/decrease for all proteins >1.2; P > 5.00E-1).RESULTSSeveral highly significant differences in the cytokine levels of dry eye patients compared with healthy controls were detected. Patients with DRYaq or those with DRYaplip showed elevated levels for most of the tested proteins. For example, IL-1β was found to be elevated 2.4-fold in DRYaq patients and 2.75-fold in DRYaqlip patients (both P < 8.00E-6). The detected amounts of protein in DRYlip patients and in healthy controls showed only minimal differences (fold increase/decrease for all proteins >1.2; P > 5.00E-1).The similarity between the profiles of healthy controls and DRYlip patients justifies the assumption that the pathomechanism of this dry eye subtype is based on mechanisms other than inflammation, whereas it seems to be the case for DRYaq patients.CONCLUSIONSThe similarity between the profiles of healthy controls and DRYlip patients justifies the assumption that the pathomechanism of this dry eye subtype is based on mechanisms other than inflammation, whereas it seems to be the case for DRYaq patients. In the pathogenesis of keratoconjunctivitis sicca, immune processes are thought to play an important role. However, the exact details of the pathomechanisms are still unknown. In this study, the expression patterns of proinflammatory cytokines in the tears of patients with different subtypes of dry eye were analyzed. One hundred forty-three subjects subdivided into healthy controls (CTRL, n = 38), patients with aqueous-deficient dry eye (DRYaq, n = 35), patients with changes of the lipid layer (DRYlip, n = 36), and patients with a combination of both (DRYaplip, n = 34) were examined. Expression patterns of proteins (e.g., IL-1β, IL-6, ITNF-α, and IFN-γ) were examined using an advanced antibody microarray approach. Several highly significant differences in the cytokine levels of dry eye patients compared with healthy controls were detected. Patients with DRYaq or those with DRYaplip showed elevated levels for most of the tested proteins. For example, IL-1β was found to be elevated 2.4-fold in DRYaq patients and 2.75-fold in DRYaqlip patients (both P < 8.00E-6). The detected amounts of protein in DRYlip patients and in healthy controls showed only minimal differences (fold increase/decrease for all proteins >1.2; P > 5.00E-1). The similarity between the profiles of healthy controls and DRYlip patients justifies the assumption that the pathomechanism of this dry eye subtype is based on mechanisms other than inflammation, whereas it seems to be the case for DRYaq patients. |
| Author | Wiegand, Michaela Grus, Franz H Boehm, Nils Riechardt, Aline I Pfeiffer, Norbert |
| Author_xml | – sequence: 1 givenname: Nils surname: Boehm fullname: Boehm, Nils organization: Experimental Ophthalmology, Department of Ophthalmology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany – sequence: 2 givenname: Aline I surname: Riechardt fullname: Riechardt, Aline I – sequence: 3 givenname: Michaela surname: Wiegand fullname: Wiegand, Michaela – sequence: 4 givenname: Norbert surname: Pfeiffer fullname: Pfeiffer, Norbert – sequence: 5 givenname: Franz H surname: Grus fullname: Grus, Franz H |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21775656$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkM1LxDAUxIOsuB968yy5eao2aZO0R1n8ggU96Lm8tC8SbZM1SYX-91ZcwdMb3vwYhlmThfMOCTln-RVjUl1b_xVnlSku5RFZMSF4JlRVLP7pJVnH-J7nnDGen5AlZ0oJKeSK6OfgrTM9DAMkHybaTsl_WId0H7yxvXVv1BuaEEKkJviBdjOE0-xDsuhSpHqiA4KLPxy4ZLXv5o9tg4cQYIqn5NhAH_HscDfk9e72ZfuQ7Z7uH7c3u6wthEyZ7oQoBC_KArHTsm6lQqharGtlQOqiBIlgSuBlCVUtawbSVCVAx3RnOFR8Qy5_c-fmnyPG1Aw2ttj34NCPsalqUQk1TzKTFwdy1AN2zT7YAcLU_M3CvwE2Qmjj |
| CitedBy_id | crossref_primary_10_1097_ICO_0000000000000256 crossref_primary_10_1136_bjophthalmol_2012_302868 crossref_primary_10_1016_j_exer_2022_109121 crossref_primary_10_1371_journal_pone_0137186 crossref_primary_10_1002_prca_201400084 crossref_primary_10_1097_ICL_0b013e3182a2f8fa crossref_primary_10_1016_j_exer_2022_109127 crossref_primary_10_1016_j_jtos_2018_05_001 crossref_primary_10_1167_iovs_65_2_16 crossref_primary_10_1177_1120672118795399 crossref_primary_10_1089_jop_2015_0029 crossref_primary_10_1186_s40662_014_0006_y crossref_primary_10_1016_j_exer_2013_08_013 crossref_primary_10_1080_08164622_2025_2485236 crossref_primary_10_1016_j_jtos_2018_04_007 crossref_primary_10_1016_j_bbmt_2015_08_020 crossref_primary_10_3390_bios14100483 crossref_primary_10_1097_ICL_0000000000000158 crossref_primary_10_1016_j_exer_2013_07_015 crossref_primary_10_1080_02713683_2022_2162088 crossref_primary_10_1002_mas_21612 crossref_primary_10_1097_ICO_0000000000001238 crossref_primary_10_1155_2014_320906 crossref_primary_10_1016_j_jtos_2013_04_004 crossref_primary_10_1186_s13167_016_0065_3 crossref_primary_10_1080_02713683_2019_1604972 crossref_primary_10_4103_ijo_IJO_405_17 crossref_primary_10_1016_j_exer_2022_109035 crossref_primary_10_1016_j_jtos_2017_05_011 crossref_primary_10_1111_jcmm_12495 crossref_primary_10_3390_pharmaceutics15030990 crossref_primary_10_1155_2014_570685 crossref_primary_10_1007_s13167_021_00265_y crossref_primary_10_1016_j_ajo_2014_03_002 crossref_primary_10_1016_j_ajo_2019_01_002 crossref_primary_10_1097_ICL_0000000000000182 crossref_primary_10_1016_j_clae_2017_05_008 crossref_primary_10_1016_j_oftal_2016_12_009 crossref_primary_10_1016_j_jtos_2014_02_002 crossref_primary_10_1016_j_oftale_2016_12_005 crossref_primary_10_4252_wjsc_v17_i4_101891 crossref_primary_10_1002_jcp_27895 crossref_primary_10_3390_bioengineering11010039 crossref_primary_10_3390_ijms25074019 crossref_primary_10_1007_s12020_017_1467_2 crossref_primary_10_1186_s12929_022_00821_2 crossref_primary_10_1016_j_jtos_2014_01_004 crossref_primary_10_1016_j_jtos_2021_07_006 crossref_primary_10_11603_mcch_2410_681X_2025_i2_15521 crossref_primary_10_1167_iovs_66_11_76 crossref_primary_10_1016_j_baga_2015_05_001 crossref_primary_10_1016_j_cyto_2018_05_013 crossref_primary_10_1371_journal_pone_0143131 crossref_primary_10_3390_ijms20010009 crossref_primary_10_1097_ACI_0b013e328357b488 crossref_primary_10_1016_j_autrev_2021_102933 crossref_primary_10_1016_j_preteyeres_2012_06_002 crossref_primary_10_1016_j_exer_2023_109679 crossref_primary_10_1097_ICO_0000000000000721 crossref_primary_10_1097_ICL_0000000000000558 crossref_primary_10_1016_j_jtos_2017_03_006 crossref_primary_10_1016_j_exer_2020_108209 crossref_primary_10_3341_kjo_2016_30_4_302 crossref_primary_10_1371_journal_pone_0051979 crossref_primary_10_1080_09273948_2018_1497664 crossref_primary_10_1186_s13063_017_1861_3 crossref_primary_10_3390_bios13070670 crossref_primary_10_3390_cells8060620 crossref_primary_10_1007_s11095_019_2569_8 crossref_primary_10_3389_fonc_2019_00882 crossref_primary_10_1097_ICL_0000000000000042 crossref_primary_10_1016_j_exer_2015_08_024 crossref_primary_10_2174_0929867326666190627131300 crossref_primary_10_1016_j_ophtha_2016_07_028 crossref_primary_10_1016_j_preteyeres_2025_101338 crossref_primary_10_1038_s41598_017_13817_y crossref_primary_10_1097_MD_0000000000040669 crossref_primary_10_1177_1753425913498912 crossref_primary_10_1016_j_exer_2015_02_013 crossref_primary_10_1080_09273948_2022_2046794 crossref_primary_10_1136_bjophthalmol_2015_307586 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1167/iovs.11-7266 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1552-5783 |
| ExternalDocumentID | 21775656 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- 18M 2WC 34G 39C 5GY 5RE ACGFO ACNCT ADBBV AENEX AFOSN ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P GROUPED_DOAJ GX1 N9A NPM OK1 P2P RHF RPM SJN TR2 TRV W8F WH7 WOQ WOW 7X8 |
| ID | FETCH-LOGICAL-c356t-bd55352343eedb69c67ea8ce997fa6b34a6eaf4a244a89691a6f84aad1bdf2a82 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 117 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000295467200092&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1552-5783 |
| IngestDate | Thu Sep 04 16:58:47 EDT 2025 Thu Jan 02 22:06:52 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c356t-bd55352343eedb69c67ea8ce997fa6b34a6eaf4a244a89691a6f84aad1bdf2a82 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 21775656 |
| PQID | 895857552 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_895857552 pubmed_primary_21775656 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-Sep-29 |
| PublicationDateYYYYMMDD | 2011-09-29 |
| PublicationDate_xml | – month: 09 year: 2011 text: 2011-Sep-29 day: 29 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Investigative ophthalmology & visual science |
| PublicationTitleAlternate | Invest Ophthalmol Vis Sci |
| PublicationYear | 2011 |
| References | 22186423 - Invest Ophthalmol Vis Sci. 2011;52(13):9610; author reply 9610-1 |
| References_xml | – reference: 22186423 - Invest Ophthalmol Vis Sci. 2011;52(13):9610; author reply 9610-1 |
| SSID | ssj0021120 |
| Score | 2.4023173 |
| Snippet | In the pathogenesis of keratoconjunctivitis sicca, immune processes are thought to play an important role. However, the exact details of the pathomechanisms... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 7725 |
| SubjectTerms | Adolescent Adult Aged Child Child, Preschool Dry Eye Syndromes - classification Dry Eye Syndromes - metabolism Eye Proteins - metabolism Female Humans Infant Interferon-gamma - metabolism Interleukin-1beta - metabolism Interleukin-6 - metabolism Male Middle Aged Protein Array Analysis Tears - chemistry Tears - metabolism Tumor Necrosis Factor-alpha - metabolism Young Adult |
| Title | Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21775656 https://www.proquest.com/docview/895857552 |
| Volume | 52 |
| WOSCitedRecordID | wos000295467200092&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07a8MwEBZtU0qXvh_pCw1dReKHXlMppaFLQoYWshlJliCUWKmdBvzve7KdTIUOXYyxZGN0n3WfdOfvEHqMHI3zhEaEprEhqYwEEVJo4hQLfJw6p0RTbIJPJmI2k9MuN6fq0io3c2IzUefehD3ygZA0FJOk8dPyi4SiUSG42lXQ2EW9BJhMADWfbYMIsLRpVBmDyBgBYCabvHfGB3O_ruCM8LiTR_yVWzY-ZnT8z7c7QUcducTPLRpO0Y4tztDBuAufnyM9LT0gCkCwaILr2NQr_wlNuC3dDW4Me4dDim-Fw48nOIdOtob2Vn61wrrGCwvuLfQDo8y1z-FKyOpTZanq6gJ9jF7fX95IV2SBmISyFdE5DQovSZqAt9RMGsatEsZKycFeOkkVs8qlCmiAEpLJSDEnUqXySOcuViK-RHuFL-w1wkoONXdpULoFFqaHwgF1F_DEyDDFqOsjvBm8DEAcIhOqsP67yrbD10dXrQGyZSu2kcGSiQfSefP3zbfosN3xlSSWd6jn4AO292jfrFfzqnxowAHHyXT8AwrkxpE |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Proinflammatory+cytokine+profiling+of+tears+from+dry+eye+patients+by+means+of+antibody+microarrays&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Boehm%2C+Nils&rft.au=Riechardt%2C+Aline+I&rft.au=Wiegand%2C+Michaela&rft.au=Pfeiffer%2C+Norbert&rft.date=2011-09-29&rft.eissn=1552-5783&rft.volume=52&rft.issue=10&rft.spage=7725&rft_id=info:doi/10.1167%2Fiovs.11-7266&rft_id=info%3Apmid%2F21775656&rft_id=info%3Apmid%2F21775656&rft.externalDocID=21775656 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon |